Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT?

Nature Clinical Practice Urology

Volumn 5, Issue 6, 2008, Pages 306-307

  Galvão, Daniel A ^a   Newton, R U Robert U ^a   Taaffe, Dennis R ^b   Spry, Nigel ^c  

^a EDITH COWAN UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST;

AEROBIC EXERCISE; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CRYOTHERAPY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDURANCE; EXERCISE; EXERCISE TOLERANCE; HEALTH PROGRAM; HEART DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; KINESIOTHERAPY; METABOLIC DISORDER; MORBIDITY; MORTALITY; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SHORT COURSE THERAPY; SIDE EFFECT; SUDDEN DEATH;

ANDROGEN ANTAGONISTS; CARDIOVASCULAR DISEASES; EXERCISE THERAPY; HUMANS; INCIDENCE; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RISK FACTORS; TREATMENT OUTCOME;

EID: 44949247397     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro1104     Document Type: Article

References (10)

1. Galvão DA et al. (2007) Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis 10: 340-346.
2. Keating NL et al. (2006) Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24: 4448-4456
3. Saigal CS et al. (2007) Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 110: 1493-1500
4. D'Amico AV et al. (2007) Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 25: 2420-2425
5. Tsai H K et al. (2007) Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst 99:1516-1524
6. Helmrich SP et al. (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325 147-152
7. Trovati M et al. (1984) Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care 7: 416-420
8. Wannamethee SG et al. (1998) Changes in physical activity, mortality, and incidence of coronary heart disease in older men. Lancet 351:1603-1608
9. Myers J et al. (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793-801
10. Galvão DA et al. (2006) Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 38: 2045-2052